Figure 1From: The utility of FDG-PET for assessing outcomes in oligometastatic cancer patients treated with stereotactic body radiotherapy: a cohort studyExample PET response. Coronal images of a PET scan of a patient prior to SBRT (A). Notice the hypermetabolic lesion in the liver has had a complete response at 1 month following therapy (B), and continues to have a complete response at 19 months post-therapy (C).Back to article page